CiteULike: guhjy's Annemans:L [4 articles]

Proteinuria and clinical outcomes in hypertensive patients.

American journal of hypertension, Vol. 22, No. 11. (November 2009), pp. 1137-1147.

by Ausilia Maione, Lieven Annemans, Giovanni Strippoli

posted to proteinuria bp arb acei by guhjy on 2009-11-08 12:37:25 as

Cost-Effectiveness of Early Irbesartan Treatment Versus Control (Standard Antihypertensive Medications Excluding ACE Inhibitors, Other Angiotensin-2 Receptor Antagonists, and Dihydropyridine Calcium Channel Blockers) or Late Irbesartan Treatment in Patients With Type 2 Diabetes, Hypertension, and Renal Disease

Diabetes Care, Vol. 27, No. 8. (1 August 2004), pp. 1897-1903.

by Andrew J. Palmer, Lieven Annemans, StÃ©phane Roze, et al.Mark Lamotte, Pablo Lapuerta, Roland Chen, Sylvie Gabriel, Paulo Carita, Roger A. Rodby, Dick de Zeeuw, Hans-Henrik Parving

posted to arb bp cea dm dn by guhjy on 2008-12-03 06:03:05 as

Principles of good practice for budget impact analysis: report of the ISPOR Task Force on good research practices--budget impact analysis.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, Vol. 10, No. 5. (October 2007), pp. 336-347.

by Josephine A. Mauskopf, Sean D. Sullivan, Lieven Annemans, et al.Jaime Caro, C. Daniel Mullins, Mark Nuijten, Ewa Orlewska, John Watkins, Paul Trueman

posted to rct cea by guhjy on 2008-01-08 03:02:06 as

An Asian regional analysis of cost-effectiveness of early irbesartan treatment versus conventional antihypertensive, late amlodipine, and late irbesartan treatments in patients with type 2 diabetes, hypertension, and nephropathy.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, Vol. 11, No. 3. (21 September 2008), pp. 354-364.

by L. Annemans, N. Demarteau, S. Hu, et al.T. J. Lee, Z. Morad, T. Supaporn, W. C. Yang, A. J. Palmer

posted to arb asia cea dn rct tw uae by guhjy on 2007-11-15 09:29:10 as

	Proteinuria and clinical outcomes in hypertensive patients. [My Copy] American journal of hypertension, Vol. 22, No. 11. (November 2009), pp. 1137-1147. by Ausilia Maione, Lieven Annemans, Giovanni Strippoli posted to proteinuria bp arb acei by guhjy on 2009-11-08 12:37:25 as
	Cost-Effectiveness of Early Irbesartan Treatment Versus Control (Standard Antihypertensive Medications Excluding ACE Inhibitors, Other Angiotensin-2 Receptor Antagonists, and Dihydropyridine Calcium Channel Blockers) or Late Irbesartan Treatment in Patients With Type 2 Diabetes, Hypertension, and Renal Disease [My Copy] Diabetes Care, Vol. 27, No. 8. (1 August 2004), pp. 1897-1903. by Andrew J. Palmer, Lieven Annemans, StÃ©phane Roze, et al.Mark Lamotte, Pablo Lapuerta, Roland Chen, Sylvie Gabriel, Paulo Carita, Roger A. Rodby, Dick de Zeeuw, Hans-Henrik Parving posted to arb bp cea dm dn by guhjy on 2008-12-03 06:03:05 as
	Principles of good practice for budget impact analysis: report of the ISPOR Task Force on good research practices--budget impact analysis. [My Copy] Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, Vol. 10, No. 5. (October 2007), pp. 336-347. by Josephine A. Mauskopf, Sean D. Sullivan, Lieven Annemans, et al.Jaime Caro, C. Daniel Mullins, Mark Nuijten, Ewa Orlewska, John Watkins, Paul Trueman posted to rct cea by guhjy on 2008-01-08 03:02:06 as
	An Asian regional analysis of cost-effectiveness of early irbesartan treatment versus conventional antihypertensive, late amlodipine, and late irbesartan treatments in patients with type 2 diabetes, hypertension, and nephropathy. [My Copy] Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, Vol. 11, No. 3. (21 September 2008), pp. 354-364. by L. Annemans, N. Demarteau, S. Hu, et al.T. J. Lee, Z. Morad, T. Supaporn, W. C. Yang, A. J. Palmer posted to arb asia cea dn rct tw uae by guhjy on 2007-11-15 09:29:10 as

guhjy's Annemans:L [4 articles] Export

guhjy's tags

ckd	1741
rct	1203
dn	1128
dm	1044
cancer	1041
ma	979
cv	926
hd	859
tgfb	834
snp	766
bp	644
ros	610
meta-analysis	516
uae	500
kidney	496
mouse	490
stats	480
software	463
mirna	450
genetics	448
pt	443
proteomics	412
mortality	408
rat	383
fbl	377
tw	372
inflammation	371
proteinuria	356
pcr	353
db	337
mtor	335
acei	333
gdl	331
mc	329
akt	327
test	325
method	323
1	323
inhibitor	322
irs	321
urine	319
arb	316
age	311
apoptosis	311
ms	310
aging	308
hcv	304
r	294
aii	289
biomarker	287
hg	283
ppi	282
bias	277
bayes	275
gwa	269
aki	269
emt	260
s6k	258
pi3k	255
nutrition	255
rnai	248
egfr	244
p53	243
ub	241
obesity	236
fibrosis	236
cox	229
smad	228
drug	225
pbmc	223
erk	222
hcc	216
metab	214
hypoxia	212
gn	210
herb	204
nfkb	203
stz	194
collagen	191
albumin	189
lc	187
hif	182
pubmed	179
longitudinal	179
lmm	178
gfr	174
p38	172
ua	170
epigenetics	169
bioinf	166
pkc	165
japan	165
power	163
cea	163
gender	162
rage	162
dna-damage	161
lead	160
cadmium	158
ref	154
genomics	151
vitamin-d	148
stata	147
ctgf	147
network	146
liver	146
book	145
company	144
screening	137
diet	136
rt	136
seq	133
mt	133
phosphorylation	132
go	128
kinase	128
protein	128
pathway	127
cell-cycle	126
no	125
systems-biology	124
esrd	123
insulin	119
lipid	118
creatinine	117
statin	116
proliferation	112
mapk	109
senescence	109
podocyte	106
fish	104
regression	103
tnf	103
cad	102
case-control	102
pd	102
gfr-formula	102
imputation	101
stat	101
multiplicity	100
imaging	100
rx	99
observational	98
p21	98
hypertrophy	98
plasmid	96
pediatric	96
nox	96
pparg	96
cloning	96
methylation	95
recurrent	94
sirt	93
blood	93
betel	93
chf	91
at1	91
nhanes	90
src	89
website	89
immunity	88
phenotype	88
anemia	88
ko	87
diagnosis	87
lr	86
toxicology	86
uti	85
epo	84
ebm	84
cytokine	84
review	84
china	83
environment	82
p	81
nonp	81
oat	81
ca	81
cachexia	81
hapmap	80
gout	78
autophagy	78
primer	78
qms	77
gene-therapy	75
egf	75
signaling	75
missing	73
cox2	73
promoter	73
surrogate	72
lpd	72
eqtl	72
gene-list	72
eif	72
stone	72
ace	72
mv	71
p-value	71
ampk	71
salt	70
gpcr	69
phd	69
4ebp	69
mgo	68
jnk	68
foxo	67
uncertainty	66
glycemia	66
normalization	65
pe	65
hts	65
chinese	65
tin	65
mirna-target	65
association	64
shc	64
hsp	63
yeast	63
2dge	63
causation	63
enddysf	63
acid-base	63
pla2	63
uuo	63
ifn	63
smoking	62
llcpk1	62
simulation	62
translation	62
me	62
ptm	61
nrk49f	61
avf	61
confounding	61
oglcnac	61
change	60
mmp	60
outcome	60
infection	60
sas	60
melamine	60
pai1	59
cost	59
oral	59
crp	59
alcohol	58
hk2	58
pls	57
urate-transporter	57
fluorescence	57
robust	57
model-selection	57
achr	57
aceiarb	56
rho	56
calibration	56
semantic	56
pdgf	56
ncrna	55
competing-risk	55
goldstd	55
ace2	55
ratio	55
estrogen	54
rapamycin	54
ckd-progression	54
iron	54
function	54
stem-cell	54
workflow	54
bone	54
vegf	54
std	53
k	53
cyclin-d1	53
dipstick	53
pld	53
hsc	53
renoprotection	53
fgf	52
il6	52
tf	52
dimerization	52
qc	52
histone	52
atm	52
normoalbuminuria	51
pth	51
epidemiology	51
ab	51
lod	51
hdac	51
matlab	50
graph	50
mercury	50
risk-ratio	50
reasoning	50
adpkd	50
arsenic	50
wnt	49
gene-environment	49
klotho	49
epistasis	49
antibiotics	49
ukm	48
nrk52e	48
breakpoint	48
ffpe	48
p27	48
endothelium	48
ngal	48
core-curriculum	48
spot-urine	47
joint-model	47
hepatocyte	47
irs1	47
pooling	47
hgf	46
aspirin	46
pdk	46
fdr	46
protein-microarray	46
dub	46
cystatin	46
aldosterone	46
metal	45
writing	45
fgf23	45
biosensor	45
semip	45
ras	45
prevention	45
ecm	45
ccb	44
sumo	44
diuretics	44
ancova	44
interaction	44
er-stress	44
variability	44
tgfbr	44
mesangial	44
metformin	44
bia	43
na	43
klf	43
enos	43
design	43
cnv	43
sle	43
dbdb	43
mtorc1	43
icu	42
asia	42
roc	42
good	42
stroke	42
agreement	42
bmi	42
qtl	41
fuzzy	41
catenin	40
risk	40
tlr	40
alignment	40
sage	40
hyperfiltration	40
wga	40
gene-targeting	40
dry-bw	39
igf	39
rca	39
angiogenesis	39
urinalysis	39
ap1	39
fibronectin	38
omics	38
tea	38
igan	38
myc	38
protein-complex	38
rvh	38
emr	37
adh	37
hematuria	37
fabp	37
propensity	37
antisense	37
bh4	37
vsmc	37
haplotype	37
gsk	37
adenosine	36
il1	36
snx	36
proteasome	36
web20	36
cardiorenal	36
megalin	36
s100b	36
animal	36
inflammasome	36
rsk	35
candidate-gene	35
cre	35
annotation	35
adduct	35
threshold	35
chemogenomics	35
subgroup	35
coffee	35
exercise	35
calcification	35
sp1	35
reverse-epidemiology	35
sepsis	34
msm	34
pathology	34
creb	34
attrition	34
effect-size	34
cross-species	34
gsk3	34
nephrotoxicity	34
cage	33
zeb	33
ns	33
sarcopenia	33
ecology	33
sglt	33
integrin	33
bmp	33
end-point	32
affy	32
mtorc2	32
addgene	32
zfn	32
browser	32
macrophage	32
ai	32
fc	32
steroid	32
text-mining	32
set	32
orbitrap	32
et	32
rtk	32
heritability	31
frailty	31
abp	31
pp2a	31
transactivation	31
silac	31
blast	31
emsa	31
pka	31
risk-difference	31
family	31
gllamm	31
hospitalization	31
agt	31
geo	30
grn	30
reporter	30
carcinogen	30
transporter	30
mw	30
aa	30
staging	30
membrane-protein	30
s100	30
notch	30
knockout	30
validation	29
extraction	29
virus	29
pten	29
ub-ligase	29
perindopril	29
cr	29
nicotinic	29
3	29
nutrient	29
human	29
igf1	28
acetylation	28
race	28
mutagenesis	28
scaling	28
renin	28
pharmacogenetics	28
gee	28
time-dependent	28
hplc	28
spla2	27
thesis	27
ck2	27
jun	27